Among the myriad tumor-associated Ags being investigated as potential CAR T cell targets, human epidermal growth factor receptor 2 (HER2) stands out as a versatile candidate due to its expression in many solid tumors, including breast, colon, and head and neck squamous cell carcinoma (13–15). The gene discussed is ERBB2; the disease is neoplasm.